Yu. M. Lopatin

7.7k total citations · 1 hit paper
59 papers, 643 citations indexed

About

Yu. M. Lopatin is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Yu. M. Lopatin has authored 59 papers receiving a total of 643 indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Cardiology and Cardiovascular Medicine, 8 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Yu. M. Lopatin's work include Heart Failure Treatment and Management (28 papers), Cardiovascular Function and Risk Factors (21 papers) and Cardiac pacing and defibrillation studies (9 papers). Yu. M. Lopatin is often cited by papers focused on Heart Failure Treatment and Management (28 papers), Cardiovascular Function and Risk Factors (21 papers) and Cardiac pacing and defibrillation studies (9 papers). Yu. M. Lopatin collaborates with scholars based in Russia, United Kingdom and Italy. Yu. M. Lopatin's co-authors include Petar Seferović, Andrew J.S. Coats, Ivan Milinković, Mitja Lainščak, Ewa A. Jankowska, Marija Polovina, Giuseppe Rosano, Adam Timmis, Aldo P. Maggioni and Radu Huculeci and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Heart Journal and European Journal of Heart Failure.

In The Last Decade

Yu. M. Lopatin

46 papers receiving 625 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Heart Failure Association Atlas : Heart Failure Epidemiology and Management Statistics 2019

2021 165 citations Petar Seferović, Ewa A. Jankowska et al. European Journal of Heart Failure profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yu. M. Lopatin Russia	14	518	64	61	58	54	59	643
Kim P. Wagenaar Netherlands	6	534 1.0×	72 1.1×	66 1.1×	61 1.1×	51 0.9×	7	646
Alexander Limburg Netherlands	5	634 1.2×	106 1.7×	87 1.4×	82 1.4×	70 1.3×	9	791
Graham Cole United Kingdom	2	553 1.1×	67 1.0×	66 1.1×	82 1.4×	45 0.8×	2	691
Ivan Milinković Serbia	12	430 0.8×	76 1.2×	89 1.5×	59 1.0×	55 1.0×	26	537
Joanne Simpson United Kingdom	11	414 0.8×	93 1.5×	54 0.9×	102 1.8×	38 0.7×	23	675
Marcel A.J. Landman Netherlands	7	729 1.4×	105 1.6×	90 1.5×	94 1.6×	69 1.3×	11	892
Ian Dawkins Ireland	9	513 1.0×	78 1.2×	100 1.6×	36 0.6×	31 0.6×	18	650
Dor Lotan United States	9	397 0.8×	93 1.5×	43 0.7×	68 1.2×	81 1.5×	44	592
Jean‐Christophe Eicher France	12	458 0.9×	76 1.2×	28 0.5×	81 1.4×	107 2.0×	19	610
Pedro Silva Cunha Portugal	15	450 0.9×	183 2.9×	75 1.2×	57 1.0×	44 0.8×	121	697

Countries citing papers authored by Yu. M. Lopatin

Since Specialization

Citations

This map shows the geographic impact of Yu. M. Lopatin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu. M. Lopatin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu. M. Lopatin more than expected).

Fields of papers citing papers by Yu. M. Lopatin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu. M. Lopatin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu. M. Lopatin. The network helps show where Yu. M. Lopatin may publish in the future.

Co-authorship network of co-authors of Yu. M. Lopatin

This figure shows the co-authorship network connecting the top 25 collaborators of Yu. M. Lopatin. A scholar is included among the top collaborators of Yu. M. Lopatin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu. M. Lopatin. Yu. M. Lopatin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lopatin, Yu. M., С. В. Недогода, А. S. Galyavich, et al.. (2023). The efficacy of antihypertensive therapy according to the results of the CONSONANCE program: is achieving the target blood pressure level the sole criterion?. Arterial’naya Gipertenziya (Arterial Hypertension). 29(4). 419–431. 2 indexed citations

Vazir, Ali, Chris J. Kapelios, Marco Metra, et al.. (2023). Decongestion Strategies In Patients Presenting with Acutely Decompensated Heart Failure: A Worldwide Survey Among Physicians. European Journal of Heart Failure. 25(9). 1555–1570. 5 indexed citations

Boytsov, S. А., С. Н. Терещенко, S. V. Villevalde, et al.. (2023). Practical aspects of vericiguat therapy in patients with heart failure with reduced ejection fraction. Expert council resolution. SHILAP Revista de lepidopterología. 28(4). 5423–5423. 1 indexed citations

Lopatin, Yu. M., et al.. (2022). Self-care as the Basis of the Mobile Application for Patients with Chronic Coronary Syndromes. SHILAP Revista de lepidopterología. 18(3). 268–273.

Конради, А. О., А. S. Galyavich, В. В. Кашталап, et al.. (2021). Practical efficacy and safety of Konsilar D24 in patients with hypertension: data from the KONSONANS program. SHILAP Revista de lepidopterología. 26(9). 4651–4651. 2 indexed citations

Lopatin, Yu. M., С. В. Недогода, М. В. Архипов, et al.. (2021). Pharmacoepidemiological analysis of routine management of heart failure patients in the Russian Federation. Part I. SHILAP Revista de lepidopterología. 26(4). 4368–4368. 4 indexed citations

Зыков, М. В., et al.. (2021). Findings from the EMPEROR-Reduced study are a tool to improve care for patients with chronic heart failure with reduced ejection fraction.Resolution of the Regional Scientific Meeting of Experts of the Southern Federal District. 2(2). 104–110. 1 indexed citations

Seferović, Petar, Ewa A. Jankowska, Andrew J.S. Coats, et al.. (2020). The Heart Failure Association Atlas: Rationale, Objectives, and Methods. European Journal of Heart Failure. 22(4). 638–645. 28 indexed citations

Jaarsma, Tiny, Jelena Čelutkienė, Yu. M. Lopatin, et al.. (2020). Learning Together: Insights from the First Heart Failure Association Patient Forum. European Journal of Heart Failure. 22(11). 1939–1940. 1 indexed citations

10.

Marzilli, Mario, Dragoş Vinereanu, Gary D. Lopaschuk, et al.. (2019). Trimetazidine in cardiovascular medicine. International Journal of Cardiology. 293. 39–44. 59 indexed citations

11.

Kobalava, Zhanna, А. О. Конради, С. В. Недогода, et al.. (2018). Russian Society of Cardiology position paper on 2018 Guidelines of the European Society of Cardiology/European Society of Arterial Hypertension for the management of arterial hypertension. Russian Journal of Cardiology. 131–142. 27 indexed citations

12.

Milinković, Ivan, Andrew J.S. Coats, Giuseppe Rosano, Yu. M. Lopatin, & Petar Seferović. (2017). Clinical benefits of treating angina directly at the cardiac cell level with trimetazidine. Monash University Research Portal (Monash University). 72(72). 25–31.

13.

Lopatin, Yu. M.. (2017). Randomized Controlled Trials in Patients With Heart Failure in Russia Following the Study Topcat: What Awaits us in the Future. Kardiologiia. 17(8). 47–50. 2 indexed citations

14.

Lopatin, Yu. M., et al.. (2017). The use of platform for remote monitoring on the base of mobile app for improving self-care in patients with chronic heart failure. Kardiologiia. 17(S4). 11–18. 13 indexed citations

15.

Lopatin, Yu. M., et al.. (2016). RATIONALE FOR APPLICATION, AND BENEFITS OF TRIMETAZIDINE IN HEART FAILURE BY ITS INFLUENCE OF MYOCARDIUM METABOLISM. Russian Journal of Cardiology. 70–79. 3 indexed citations

16.

Lopatin, Yu. M., et al.. (2016). RELIABILITY AND DISCRIMINANT VALIDITY OF THE RUSSIAN VERSION OF EUROPEAN SELF-CARE BEHAVIOUR SCALE IN CHRONIC HEART FAILURE. Russian Journal of Cardiology. 14–19. 4 indexed citations

17.

Lopatin, Yu. M. & Cristiana Vitale. (2016). Effect of ivabradine on central aortic blood pressure in patients with stable coronary artery disease: What do we know?. International Journal of Cardiology. 224. 145–148. 5 indexed citations

18.

Lopatin, Yu. M., et al.. (2013). Pulse wave velocity as a cardiovascular risk marker in patients with stable coronary heart disease. SHILAP Revista de lepidopterología. 1 indexed citations

19.

Lopatin, Yu. M., et al.. (2013). Pulse wave velocity as a cardiovascular risk marker in patients with stable coronary heart disease. Russian Journal of Cardiology. 12–17.

20.

Семенова, Н. В., et al.. (2003). Effects of indapamid retard on cardiovascular remodeling processes in patients with arterial hypertension. Arterial’naya Gipertenziya (Arterial Hypertension). 9(5). 167–171. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact